Avidity Biosciences
RNAM
#1851
Rank
NZ$19.33 B
Marketcap
NZ$125.14
Share price
0.00%
Change (1 day)
132.16%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: NZ$19.33 Billion

As of June 2026 Avidity Biosciences has a market cap of NZ$19.33 Billion. This makes Avidity Biosciences the world's 1851th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.33 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$251.71 B 1,202.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$176.60 B 813.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.88 B-85.09%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$10.50 B-45.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.38 B-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.78 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$6.59 B-65.90%๐Ÿ‡บ๐Ÿ‡ธ USA